Xenon Pharmaceuticals Inc

XENENASDAQUSD
65.59 USD
1.79 (2.81%)🟢PRE MARKET (AS OF 04:10 AM EDT)
🟢Market: OPEN

Xenon Pharmaceuticals Inc (XENE) is currently trading at $65.59. Our models show a "Buy" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, XENE trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Aug 26, 2026.

Open?$63.02
High?$65.59
Low?$63.02
Prev. Close?$63.79
Volume?N/A
Avg. Volume?707.6K
Bid / Ask
Bid?$54.70 × 100
Ask?$74.67 × 100
Spread?$19.97
Midpoint?$64.69
Valuation & Ratios
Market Cap?6.2B
Shares Out?96.7M
Float?90.9M
Float %?94.0%
P/E Ratio?N/A
P/B Ratio?4.97
EPS?-$4.23
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Employees
370
Market Cap
5.9B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2014-11-05
Address
200 - 3650 GILMORE WAY
BURNABY,
Phone: (604) 484-3300
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+1/3)
Medium-Term (Wave)? Neutral(0/3)
Short-Term (Ripple)? Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
38
Piotroski F-Score?0/9Weak
Altman Z-Score?67.57Safe
Confidence?52%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?6.24%Elevated
Short Interest?5.7M
Days to Cover?9.2
Free Float90.9M
Avg Daily Volume618.6K
Settlement Date2026-08-14
Financial Health
Current Ratio?21.02Strong
Quick Ratio?21.02Strong
Cash Ratio?2.66Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A
P/B?
Peers
100
S&P
37
4.97FAIR
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
S&P
97
-13.8CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
S&P
6
-32.9%WEAK
ROA?
S&P
3
-31.6%WEAK
Cash Flow & Enterprise
FCF?$-338527000
Enterprise Value?$6.1B
Fundamentals ratios updated end of day